Study Group: Former C-Level Executives in the Healthcare Council in Member Programs(?)

United Therapeutics, a profitable US biotech company is about 12 months away from FDA approval of Inhaled Treprostinil for Pulmonary Arterial Hypertension.  This drug will significantly add to the Company’s current 60% prostacyclin market share and help ensure the continued 30% revenue growth rate...

Pfizer attempts to leverage their original purchase by a sale of assets and retention of portions of the Esperion assets.  They appear to be retaining a portion of the research of the company while divesting the remaining technology.  They are keeping a small equity position in Esperion...

Microbes have a remarkable ability to mutate to allow for their survival.  Biologics can introduce new means of treating invections, but are unlikely to overcome the ability of them to become resistant.  Several biological components have been studied by companies and claim lack of resistance....

Have a daughter who is a retired school teacher. She was required to perform in life's real world as a student teacher for a period of roughly six months prior to her graduation. Points of requirement:  1.  Opportunity to observe the teacher who was her mentor and evaluator. 2. ...

Stem cells have a great potential for a wide range of medical treatments.  Laying out the direction to allow for clinical studies is an important step. Cancer Stem cell research is a new area where modulation of stem cell activity may prevent metastatic events.  The FDA's concern for embryonic...